Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binod Dhakal

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Blood|July 6, 2019
Myeloma sleeper agent in myeloid disguiseBinod Dhakal, Siegfried Janz
Journal of Hematology & Oncology|July 28, 2023
BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual MeetingJames F Wu, Binod Dhakal
JAMA Oncology|August 12, 2018
Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma-ReplyBinod Dhakal, Aniko Szabo, Parameswaran Hari
Haematologica|December 24, 2025
Translocation t(11;14) and BCL2-inhibition in multiple myelomaShirlene Sim, Binod Dhakal, Hang Quach
JCO Oncology Practice|May 18, 2021
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm ShiftMeera Mohan, Parameswaran Hari, Binod Dhakal
F1000Research|September 10, 2016
Recent advances in understanding multiple myelomaBinod Dhakal, Saulius Girnius, Parameswaran Hari
Translational Research : the Journal of Laboratory and Clinical Medicine|October 11, 2018
Novel biomarkers in multiple myelomaAdam Levin, Parameswaran Hari, Binod Dhakal
Blood Reviews|December 11, 2019
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myelomaAgne Paner, Pritesh Patel, Binod Dhakal
Acta Haematologica|December 29, 2024
Novel Approaches of Cellular Therapy in Multiple Myeloma: Focus on Chimeric Antigen Receptor T-CellsRavi Kishore Narra, Supriya Peshin, Binod Dhakal
Leukemia|June 2, 2020
Multiple myeloma and COVID-19Binod Dhakal, Anita D'Souza, Saurabh Chhabra, et al.
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Blood|July 6, 2019
Myeloma sleeper agent in myeloid disguiseBinod Dhakal, Siegfried Janz
Journal of Hematology & Oncology|July 28, 2023
BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual MeetingJames F Wu, Binod Dhakal
JAMA Oncology|August 12, 2018
Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma-ReplyBinod Dhakal, Aniko Szabo, Parameswaran Hari
Haematologica|December 24, 2025
Translocation t(11;14) and BCL2-inhibition in multiple myelomaShirlene Sim, Binod Dhakal, Hang Quach
JCO Oncology Practice|May 18, 2021
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm ShiftMeera Mohan, Parameswaran Hari, Binod Dhakal
F1000Research|September 10, 2016
Recent advances in understanding multiple myelomaBinod Dhakal, Saulius Girnius, Parameswaran Hari
Translational Research : the Journal of Laboratory and Clinical Medicine|October 11, 2018
Novel biomarkers in multiple myelomaAdam Levin, Parameswaran Hari, Binod Dhakal
Blood Reviews|December 11, 2019
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myelomaAgne Paner, Pritesh Patel, Binod Dhakal
Acta Haematologica|December 29, 2024
Novel Approaches of Cellular Therapy in Multiple Myeloma: Focus on Chimeric Antigen Receptor T-CellsRavi Kishore Narra, Supriya Peshin, Binod Dhakal
Leukemia|June 2, 2020
Multiple myeloma and COVID-19Binod Dhakal, Anita D'Souza, Saurabh Chhabra, et al.
Pageof 18